The positive impact of the Life's Essential 8 in the prevention of incident heart failure

• by Patricio Lopez-Jaramillo, Mavel Lopez-Flecher, Jose P Lopez-Lopez

• February 8, 2025

Molecular and cellular adaptations to extended hypothermic oxygenated perfusion in donation-after-circulatory-death hearts in a porcine model

• by Morgan K. Moroi, Yaagnik Kosuri, Cary Karcher, Diana Albino, Anthony Campbell, Arianna Adamo, Emre Bektik, Christine Chan, Kenmond Fung, Miroslav Sekulic, Shaheer K. Faruqi, Craig J. Goergen, Melissa Tamimi, Koji Takeda, Giovanni Ferrari

• May 25, 2026

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.

• by Kathryn Wighton

• May 27, 2026

• 5 min

Global evidence on the cost-effectiveness of cardiac resynchronization therapy for heart failure: a systematic review

• by Kaltrina Bajraktari, Zanfina Ademi, Artan Bajraktari, Roberta Bajrami, Besfort Kryeziu, Robert J. Gil, Michael Y. Henein, Gani Bajraktari

• May 21, 2026